2007
DOI: 10.1086/518127
|View full text |Cite
|
Sign up to set email alerts
|

Red-Green Color Vision Impairment in Duchenne Muscular Dystrophy

Abstract: The present study evaluated the color vision of 44 patients with Duchenne muscular dystrophy (DMD) (mean age 14.8 years; SD 4.9) who were submitted to a battery of four different color tests: Cambridge Colour Test (CCT), Neitz Anomaloscope, Ishihara, and American Optical Hardy-Rand-Rittler (AO H-R-R). Patients were divided into two groups according to the region of deletion in the dystrophin gene: upstream of exon 30 (n=12) and downstream of exon 30 (n=32). The control group was composed of 70 age-matched heal… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

0
55
0
7

Year Published

2009
2009
2020
2020

Publication Types

Select...
8
1

Relationship

1
8

Authors

Journals

citations
Cited by 68 publications
(63 citation statements)
references
References 54 publications
0
55
0
7
Order By: Relevance
“…Several studies in our laboratory show changes in visual functions in many neurological patients with normal ophthalmologic diagnosis [20][21][22].…”
Section: Discussionmentioning
confidence: 92%
“…Several studies in our laboratory show changes in visual functions in many neurological patients with normal ophthalmologic diagnosis [20][21][22].…”
Section: Discussionmentioning
confidence: 92%
“…Cardiac or respiratory complications are life-threatening. DMD may also be accompanied by non-muscle symptoms [1], including mental retardation [2], red-green color vision impairment [3], electroretinogram abnormalities [4] and short stature [5,6].…”
Section: Introductionmentioning
confidence: 99%
“…22 The cause of the b-wave reduction in both humans and mouse models is thus still not understood. Moreover, a red-green color vision defect was recently reported in some DMD patients, 23 which is hard to explain with the distribution of all dystrophins other than Dp71 restricted to photoreceptor terminals. Therefore, we aimed to reassess the distribution of dystrophin proteins in the retina using a combination of laser capture microdissection combined with RT-PCR, in situ hybridization, and immunohistochemistry.…”
mentioning
confidence: 99%